ARTICLE | Finance
BioCentury’s Financial Report also features venture rounds for Alentis and Metsera; follow-ons for Zai Lab and 89bio
By Paul Bonanos, Director of Biopharma Intelligence, and Gunjan Ohri, Data Content Analyst
November 15, 2024 8:51 PM UTC
An inflammatory disease program from the University of Manchester will be the first project housed in Syncona’s new Slingshot incubator, set up to advance academic spinouts from the U.K., U.S. and Europe.
Syncona Ltd. (LSE:SYNC) has committed £12.5 million ($15.8 million) to the incubator, which will provide leadership, operational support and other resources to a pipeline built by the U.K. firm. Two Syncona partners will lead Slingshot: Managing Partner Edward Hodgkin will be its executive chair, and Executive Partner Richard Wooten its CSO…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654217/syncona-building-slingshot-incubator-trace-launches-with-101m